MediFind
Condition

Disseminated Intravascular Coagulation

Latest Research

Latest Advance
Study
  • Condition: Sepsis requiring Mechanical Ventilation
  • Journal: Critical care (London, England)
  • Treatment Used: Dexmedetomidine
  • Number of Patients: 201
  • Published —
This study tested the safety and efficacy of using dexmedetomidine to treat patients with sepsis requiring mechanical ventilation.
Latest Advance
Study
  • Condition: COVID-19
  • Journal: Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique
  • Treatment Used: Antirheumatic agents
  • Number of Patients: N/A
  • Published —
The study researched the treatment of COVID-19 with antirheumatic agents.
Latest Advance
Study
  • Condition: Amebic Liver Abscess Refractory to Metronidazole (MNZ) and Percutaneous Drainage
  • Journal: BMC surgery
  • Treatment Used: Surgical Drainage with Intraoperative Ultrasonography
  • Number of Patients: 1
  • Published —
This case report discusses a 53-year-old man with amebic liver abscess refractory to metronidazole (MNZ) treated with preoperative computed tomography (CT) and percutaneous and surgical drainage with intraoperative ultrasonography (IOUS).
Latest Advance
Study
  • Condition: Idiopathic Interstitial Pneumonia
  • Journal: BMJ open respiratory research
  • Treatment Used: Recombinant Thrombomodulin
  • Number of Patients: 85
  • Published —
In this study, researchers evaluated the effectiveness of recombinant thrombomodulin for the treatment of acute exacerbations in idiopathic interstitial pneumonia.
Latest Advance
Study
  • Condition: Huge Adenomyosis
  • Journal: BMC women's health
  • Treatment Used: Conservative Treatment
  • Number of Patients: 1
  • Published —
This case report describes a patient with huge adenomyosis that was treated using conservative treatment such as nafamostat mesilate before hysterectomy.
Latest Advance
Study
  • Condition: Disseminated Intravascular Coagulation
  • Journal: Scientific reports
  • Treatment Used: Combined Antithrombin and Thrombomodulin Therapy
  • Number of Patients: 2222
  • Published —
In this study, researchers evaluated the effectiveness of combined antithrombin and thrombomodulin therapy for the treatment of mechanically ventilated septic patients with disseminated intravascular coagulation.
Latest Advance
Study
  • Condition: Aplastic Anemia/Chronic Disseminated Intravascular Coagulation (DIC)
  • Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
  • Treatment Used: Factor XIII Concentrate
  • Number of Patients: 1
  • Published —
This study examined the effectiveness of factor XIII concentrate (used to treat or prevent bleeding) administered in a patient with bleeding after teeth extraction as a complication of aplastic anemia (condition that occurs when the body stops producing enough new blood cells) and chronic disseminated intravascular coagulation (condition in which blood clots form throughout the body, blocking small blood vessels; DIC).
Latest Advance
Study
  • Condition: Amniotic fluid embolism complicated by disseminated intravascular coagulation
  • Journal: Medicine
  • Treatment Used: Rivaroxaban
  • Number of Patients: 1
  • Published —
The study researched the effects of Rivaroxaban is safe and effective for amniotic fluid embolism complicated by disseminated intravascular coagulation.
Latest Advance
Study
  • Condition: Pneumocystis Pneumonia (PCP) after Corticosteroids in Patient with Severe Alcoholic Hepatitis (AH)
  • Journal: Medicine
  • Treatment Used: Trimethoprim-Sulfamethoxazole (TMP-SMX)
  • Number of Patients: 1
  • Published —
This case report discusses a 43-year-old alcoholic man diagnosed with severe alcoholic hepatitis (AH) and treated with oral corticosteroids for 26 days who developed pneumocystis pneumonia (PCP).
Latest Advance
Study
  • Condition: Patients with Non-Small Cell Lung Cancer (NSCLC)
  • Journal: Scientific reports
  • Treatment Used: Best Supportive Care Alone
  • Number of Patients: 860
  • Published —
This study clarified (1) the decision-making factors of BSC alone and (2) the prognostic factors after selection of no further anticancer therapies in patients with non-small cell lung cancer (NSCLC).